Current Illinois CancerCare Clinical Trals

Melanoma


A091802

Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer


S2101

Biomarker Stratified CaboZantinib (NSC#761968) and NivOlumab (NSC#748726) (BiCaZO) - A Phase II Study of Combining Cabozantinib and Nivolumab in Participants with Advanced Solid Tumors (IO Refractory Melanoma or HNSCC) Stratified by Tumor Biomarkers - an immunoMATCH Pilot Study


Search Again